Join
Live feed
·
INSIDERFilingvia Quantisnow
KalVista Pharmaceuticals Inc. logo

Chief Financial Officer Piekos Brian converted options into 5,000 shares and sold $39,882 worth of shares (1,489 units at $26.78), increasing direct ownership by 19% to 21,661 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KALV (KalVista Pharmaceuticals Inc.) and more on Quantisnow.